SCICLONE PHARMACEUTICALS INC's ticker is SCLN and the CUSIP is 80862K104. A total of 138 filers reported holding SCICLONE PHARMACEUTICALS INC in Q1 2017. The put-call ratio across all filers is 0.44 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2017 | $2,379,000 | -85.4% | 216,307 | -87.0% | 1.28% | -86.0% |
| Q1 2017 | $16,300,000 | +20.8% | 1,663,281 | +33.1% | 9.19% | +14.3% |
| Q4 2016 | $13,491,000 | -4.6% | 1,249,200 | +15.4% | 8.04% | -44.6% |
| Q2 2016 | $14,138,000 | -37.3% | 1,082,532 | -47.2% | 14.50% | -45.5% |
| Q1 2016 | $22,535,000 | +108.4% | 2,048,638 | +74.3% | 26.58% | +109.8% |
| Q4 2015 | $10,815,000 | – | 1,175,574 | – | 12.67% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Athos Capital Ltd | 284,200 | $3,126,000 | 1.80% |
| Nine Chapters Capital Management LLC | 13,600 | $150,000 | 1.42% |
| Stonepine Capital Management, LLC | 216,307 | $2,379,000 | 1.28% |
| GLG Partners LP | 1,588,897 | $17,478,000 | 0.97% |
| MENTA CAPITAL LLC | 431,996 | $4,752,000 | 0.56% |
| Sapphire Star Partners LP | 24,834 | $273,000 | 0.34% |
| Yakira Capital Management, Inc. | 85,500 | $941,000 | 0.28% |
| TFS CAPITAL LLC | 55,104 | $606,000 | 0.24% |
| BRANT POINT INVESTMENT MANAGEMENT LLC | 100,000 | $1,100,000 | 0.13% |
| GABELLI & Co INVESTMENT ADVISERS, INC. | 102,261 | $1,125,000 | 0.12% |